Alopecia Areata Clinical Trials in New York, New York
7 recruitingNew York, New York
Showing 1–7 of 7 trials
Recruiting
Phase 3
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
Alopecia Areata
AbbVie1,500 enrolled271 locationsNCT06012240
Recruiting
Utilization and Effectiveness of Ritlecitinib in a Real-World Population With Severe AA in the US
Alopecia Areata
Pfizer300 enrolled1 locationNCT07226531
Recruiting
Phase 3
A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata
Severe Alopecia Areata
Pfizer225 enrolled80 locationsNCT07029711
Recruiting
Phase 2
Dupilumab in the Treatment of Pediatric Alopecia Areata
Alopecia Areata
Icahn School of Medicine at Mount Sinai76 enrolled5 locationsNCT05866562
Recruiting
Phase 2
Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome
Alopecia AreataAtopic Dermatitis
Icahn School of Medicine at Mount Sinai56 enrolled1 locationNCT07242638
Recruiting
Phase 3
A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
Alopecia Areata
Pfizer550 enrolled114 locationsNCT06873945
Recruiting
Phase 2
Regeneron AA Multicenter (Dupilumab)
Alopecia Areata
Emma Guttman68 enrolled3 locationsNCT05551793